Synergetics USA, Inc. (SURG) Reports Mixed Q3 Results: Beats on Bottom Line, Misses on Sales
Synergetics USA, Inc. (NASDAQ: SURG) reported Q3 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $14.7 million versus the consensus estimate of $14.91 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Properties (BXP) Reports In-Line Q3 FFO, Guides Above the Street
- Logitech (LOGI) Tops Q2 EPS by 10c
- Exelon Corp. (EXC) Tops Q3 EPS by 12c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!